Skip to search formSkip to main contentSkip to account menu

PT-141

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Melanocortinergic agents are currently being investigated for a possible therapeutic role in male and female sexual dysfunction… 
2007
2007
Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized… 
Highly Cited
2006
Highly Cited
2006
INTRODUCTION Melanocortins affect multiple physiological responses, including sexual behaviors. Bremelanotide is a synthetic… 
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Highly Cited
2004
Highly Cited
2004
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following intranasal administration in healthy male subjects and… 
Highly Cited
2004
Highly Cited
2004
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following subcutaneous administration to healthy male subjects… 
Highly Cited
2004
Highly Cited
2004
Disorders of sexual desire affect an estimated 30% of women in North America and Europe, with etiologies based on interpersonal… 
Highly Cited
2003
Highly Cited
2003
Abstract: PT‐141, a synthetic peptide analogue of α‐MSH, is an agonist at melanocortin receptors including the MC3R and MC4R…